Yaro Preclinical Consulting SRL
Yaro Preclinical Consulting reported total assets of 158,481 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jan 2026).
The score of Yaro Preclinical Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +17 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Yaro Preclinical Consulting's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 7,591 € | ||||
| Equity | 157,418 € | ||||
| Cash | 93,196 € | ||||
| EBITDA | 17,133 € | ||||
| Total assets | 158,481 € |
Filed annual accounts
- Year ended 30 Jun 2025filed on 30 Jan 2026
- Year ended 30 Jun 2024filed on 24 Jan 2025
- Year ended 30 Jun 2023filed on 26 Jan 2024
- Year ended 30 Jun 2022filed on 27 Jan 2023
- Year ended 30 Jun 2021filed on 27 Jan 2022
Yaro Preclinical Consulting's financial analysis
- Solvency99.3%sector median: 56.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Yaro Preclinical Consulting
Yaro Preclinical Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0897.435.882
- VAT number
- BE0897435882
- Peppol
- Registered · 0208:0897435882 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Apr 2008
- Registered office
- 2300 Turnhout
- Latest accounts
- 2025 · filed on 30 Jan 2026
- Activity
- Manufacture of basic pharmaceutical products (NACE 21100)
Yaro Preclinical Consulting (SRL) has been based in Turnhout since 2008, active in: manufacture of basic pharmaceutical products. For 2025, it reports a net profit of 7,591 € and equity of 157,418 €; its revenue is not published. Its solvency stands at 99.3%, above the median of its sector (56.0%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Yaro Preclinical Consulting
Companies in the same business, of comparable size and area, outside its group.
- huMAN Manufacture of basic pharmaceutical products Gerpinnes · balance sheet 186,227 €
- Pneoo Business and other management consultancy activities Vosselaar · balance sheet 145,836 €
- QP Pro Services Manufacture of basic pharmaceutical products Gembloux · balance sheet 304,804 €
- MDT Services & Technologies Manufacture of basic pharmaceutical products Lontzen · balance sheet 102,386 €
- Ansorius Retail sale of pharmaceutical products Bastogne · balance sheet 174,823 €
- Medipharm Worldwide Group Manufacture of basic pharmaceutical products Tienen · balance sheet 331,081 €
- Mayaku Pharmaceutical Development Manufacture of basic pharmaceutical products Ghent · balance sheet 170,483 €
- Novozymatic Manufacture of basic pharmaceutical products Kapellen · balance sheet 148,440 €
Frequently asked questions about Yaro Preclinical Consulting
What is the revenue of Yaro Preclinical Consulting?
Yaro Preclinical Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Yaro Preclinical Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0897435882 for Yaro Preclinical Consulting, if the company is VAT-registered. Its company number (CBE) is 0897.435.882.
Where is the registered office of Yaro Preclinical Consulting?
According to the CBE register, the registered office of Yaro Preclinical Consulting is in 2300 Turnhout.
What is the equity of Yaro Preclinical Consulting?
At the close of the 2025 financial year, the equity of Yaro Preclinical Consulting amounts to 157,418 €, a solvency of 99.3% of total assets.
Who manages Yaro Preclinical Consulting?
The register lists 1 active mandates at Yaro Preclinical Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Yaro Preclinical Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →